Offerings // Quantum Biopharma Ltd.

QNTM offering history

Every offering-related filing in Quantum Biopharma Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 357 filings back to Oct 15, 2019.

Last executed offering
Dec 22, 2025
424B5 — priced deal (shares or notes)
Last registration (announced)
Dec 26, 2023
F-3 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
0
S-1/S-3/F-series registrations
DateFilingWhat it means
Dec 22, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 31, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 27, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Feb 20, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jan 4, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 26, 2023F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jul 19, 2023RW →WITHDRAWNRegistration withdrawn
Jul 31, 2020FWP →MARKETINGFree-writing prospectus — offering being marketed
QNTM offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full QNTM workspace →
QNTM offering FAQ

When did QNTM last execute an offering?

Per SEC filings, Quantum Biopharma Ltd.'s most recent priced offering document is a 424B5 filed 2025-12-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did QNTM last announce or register an offering?

The most recent registration is a F-3 filed 2023-12-26. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.